CRAI Earnings

CRAI reported its earnings on 2026-05-07, showcasing a revenue of 200.97M against an estimate of 193.29M, resulting in a 3.98% surprise. The EPS was 1.99, surpassing the expected 2.02 by -1.49%. The stock experienced a -8.86% price change on the earnings day and a -7.86% change over the next five days, reflecting market reactions to the results.

Following CRAI's earnings announcement on 2026-05-07, the stock price moved by -8.86% on the day of the release. Over the subsequent five days, it saw a -7.86% change. Historically, CRAI's stock price tends to shift by an average of -0.69% in the 10 days leading up to earnings and 3.01% in the 10 days following, providing insight into potential market.

For 2026/Q2, analysts estimate CRAI's annual revenue to reach 190.16M, while the EPS is projected at 2.19. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between CRAI's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, CRAI's stock price typically moves by -0.69% in the 10 days before its earnings and 3.01% in the 10 days after. For the upcoming 2026/Q2 earnings, analysts expect an EPS of 2.19 and revenue of 190.16M.

The earnings call reflects strong financial performance with record revenue and profitability, particularly in the Life Sciences and M&A sectors. Although there are increased costs and a restructuring charge, the company maintains a positive outlook with strong demand and utilization rates. The Q&A reveals optimism about talent acquisition and growth despite some general responses. Given the market cap, this translates to a positive stock price movement, likely between 2% to 8%.